Novartis Investigative Site

Burjassot, Valencia 46100

1 studies enrolling now · 3 studies all time

What they study most

Age-related Macular Degeneration, Geographic Atrophy Secondary to Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration

Studies at this site

• A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration — Recruiting now
• Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) — Completed
• An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study — Completed